guest ::
| Home > Publications database > ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma. > print |
| Home > Publications database > ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma. > print |
| 001 | 168091 | ||
| 005 | 20240229133557.0 | ||
| 024 | 7 | _ | |a 10.1158/2159-8290.CD-20-1066 |2 doi |
| 024 | 7 | _ | |a pmid:33741710 |2 pmid |
| 024 | 7 | _ | |a 2159-8274 |2 ISSN |
| 024 | 7 | _ | |a 2159-8290 |2 ISSN |
| 024 | 7 | _ | |a altmetric:102182677 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2021-00679 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Arabzade, Amir |b 0 |
| 245 | _ | _ | |a ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma. |
| 260 | _ | _ | |a Philadelphia, Pa. |c 2021 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1634297860_1829 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a 2021 Sep;11(9):2200-2215 |
| 520 | _ | _ | |a Over 60% of supratentorial (ST) ependymomas harbor a ZFTA-RELA (ZRfus) gene fusion (formerly C11orf95-RELA). To study the biology of ZRfus, we developed an autochthonous mouse tumor model using in utero electroporation (IUE) of the embryonic mouse brain. Integrative epigenomic and transcriptomic mapping was performed on IUE driven ZRfus tumors by CUT&RUN, ChIP, ATAC, and RNA sequencing and compared to human ZRfus driven ependymoma. In addition to direct canonical NF-kB pathway activation, ZRfus dictates a neoplastic transcriptional program and binds to thousands of unique sites across the genome that are enriched with Plagl family transcription factor (TF) motifs. ZRfus activates gene expression programs through recruitment of transcriptional co-activators (Brd4, Ep300, Cbp, Pol2) that are amenable to pharmacologic inhibition. Downstream ZRfus target genes converge on developmental programs marked by Plagl transcription factor proteins, and activate neoplastic programs enriched in Mapk, focal adhesion, and gene imprinting networks. |
| 536 | _ | _ | |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312) |0 G:(DE-HGF)POF4-312 |c POF4-312 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 700 | 1 | _ | |a Zhao, Yanhua |b 1 |
| 700 | 1 | _ | |a Varadharajan, Srinidhi |0 0000-0002-2033-0758 |b 2 |
| 700 | 1 | _ | |a Chen, Hsiao-Chi |0 0000-0002-7505-6119 |b 3 |
| 700 | 1 | _ | |a Jessa, Selin |0 0000-0003-4192-6523 |b 4 |
| 700 | 1 | _ | |a Rivas, Bryan |b 5 |
| 700 | 1 | _ | |a Stuckert, Austin J |0 0000-0002-5938-7495 |b 6 |
| 700 | 1 | _ | |a Solis, Minerva |b 7 |
| 700 | 1 | _ | |a Kardian, Alisha |b 8 |
| 700 | 1 | _ | |a Tlais, Dana |0 0000-0002-0060-8070 |b 9 |
| 700 | 1 | _ | |a Golbourn, Brian J |b 10 |
| 700 | 1 | _ | |a Stanton, Ann-Catherine J |b 11 |
| 700 | 1 | _ | |a Chan, Yuen San |b 12 |
| 700 | 1 | _ | |a Olson, Calla |b 13 |
| 700 | 1 | _ | |a Karlin, Kristen L |b 14 |
| 700 | 1 | _ | |a Kong, Kathleen |b 15 |
| 700 | 1 | _ | |a Kupp, Robert |b 16 |
| 700 | 1 | _ | |a Hu, Baoli |0 0000-0002-2737-6871 |b 17 |
| 700 | 1 | _ | |a Injac, Sarah G |0 0000-0002-6389-369X |b 18 |
| 700 | 1 | _ | |a Ngo, Madeline |0 0000-0003-3610-6475 |b 19 |
| 700 | 1 | _ | |a Wang, Peter R |b 20 |
| 700 | 1 | _ | |a De Leon, Luz A |b 21 |
| 700 | 1 | _ | |a Sahm, Felix |0 P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88 |b 22 |u dkfz |
| 700 | 1 | _ | |a Kawauchi, Daisuke |0 P:(DE-He78)0ac2bd1a9fb1823a351ee4434d80808b |b 23 |u dkfz |
| 700 | 1 | _ | |a Pfister, Stefan |0 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9 |b 24 |u dkfz |
| 700 | 1 | _ | |a Lin, Charles Y |b 25 |
| 700 | 1 | _ | |a Hodges, H Courtney |0 0000-0003-4441-497X |b 26 |
| 700 | 1 | _ | |a Singh, Irtisha |b 27 |
| 700 | 1 | _ | |a Westbrook, Thomas F |b 28 |
| 700 | 1 | _ | |a Chintagumpala, Murali M |b 29 |
| 700 | 1 | _ | |a Blaney, Susan M |b 30 |
| 700 | 1 | _ | |a Parsons, Donald W |b 31 |
| 700 | 1 | _ | |a Pajtler, Kristian W |0 P:(DE-He78)a7c1bbac024fa232d9c6b78443328d9d |b 32 |u dkfz |
| 700 | 1 | _ | |a Agnihotri, Sameer |b 33 |
| 700 | 1 | _ | |a Gilbertson, Richard J |0 0000-0001-7539-9472 |b 34 |
| 700 | 1 | _ | |a Yi, Joanna |b 35 |
| 700 | 1 | _ | |a Jabado, Nada |b 36 |
| 700 | 1 | _ | |a Kleinman, Claudia L |0 0000-0002-5158-7126 |b 37 |
| 700 | 1 | _ | |a Bertrand, Kelsey C |b 38 |
| 700 | 1 | _ | |a Deneen, Benjamin |b 39 |
| 700 | 1 | _ | |a Mack, Stephen C |0 0000-0001-9620-4742 |b 40 |
| 773 | _ | _ | |a 10.1158/2159-8290.CD-20-1066 |g p. candisc.1066.2020 - |0 PERI:(DE-600)2607892-2 |n 9 |p 2200-2215 |t Cancer discovery |v 11 |y 2021 |x 2159-8290 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:168091 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 22 |6 P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 23 |6 P:(DE-He78)0ac2bd1a9fb1823a351ee4434d80808b |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 24 |6 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 32 |6 P:(DE-He78)a7c1bbac024fa232d9c6b78443328d9d |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-312 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Funktionelle und strukturelle Genomforschung |x 0 |
| 913 | 0 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-312 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Functional and structural genomics |x 0 |
| 914 | 1 | _ | |y 2021 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2021-01-31 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2021-01-31 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2021-01-31 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-01-31 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2021-01-31 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2021-01-31 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-01-31 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2021-01-31 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CANCER DISCOV : 2019 |d 2021-01-31 |
| 915 | _ | _ | |a IF >= 25 |0 StatID:(DE-HGF)9925 |2 StatID |b CANCER DISCOV : 2019 |d 2021-01-31 |
| 920 | 1 | _ | |0 I:(DE-He78)B062-20160331 |k B062 |l B062 Pädiatrische Neuroonkologie |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)HD01-20160331 |k HD01 |l DKTK HD zentral |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)B062-20160331 |
| 980 | _ | _ | |a I:(DE-He78)HD01-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|